← Back to Patent Explorer
US4684660A Expired / Lapsed US ⏱️ 0.0 years remaining

Mercaptoacyldepeptides

Assignee: ER Squibb and Sons LLC
•
Filing: 1980-05-01
•
Granted: 1987-08-04
•
Expires: 2000-05-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds having the formula ##STR1## and alkyl esters and salts thereof. R 1 is hydrogen, alkanoyl or ##STR2## R 2 is hydrogen, alkyl, or phenylalkyl; n is 0 or 1; and A 1 and A 2 each is an α-amino or α-imino acid residue joined through a peptide bond, have useful hypotensive activity.

Inventors

  • 👤 Miquel A. Ondetti
  • 👤 Josip Pluscec

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 21:11
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06139; C07K5/06165; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 47 words
A compound having the formula ##STR12## or an alkyl ester or a salt thereof, wherein R 1 is hydrogen, or ##STR13## R 2 is hydrogen, alkyl or phenylalkyl; and A 1 and A 2 each is an α-amino or α-imino acid residue joined through a peptide bond.
Claim 2
Dependent Claim 47 words
A compound having the formula ##STR12## or an alkyl ester or a salt thereof, wherein R 1 is hydrogen, or ##STR13## R 2 is hydrogen, alkyl or phenylalkyl; and A 1 and A 2 each is an α-amino or α-imino acid residue joined through a peptide bond.
Claim 3
Dependent Claim 12 words
A compound in accordance with claim 1 wherein R 1 is hydrogen.
Claim 4
Dependent Claim 12 words
A compound in accordance with claim 1 wherein R 1 is ##STR14##
Claim 5
Dependent Claim 12 words
A compound in accordance with claim 1 wherein R 2 is hydrogen.
Claim 6
Dependent Claim 12 words
A compound in accordance with claim 1 wherein R 2 is alkyl.
Claim 7
Dependent Claim 12 words
A compound in accordance with claim 1 wherein R 2 is phenylalkyl.
Claim 8
Dependent Claim 23 words
A compound in accordance with claim 1 wherein A 1 is an α-amino acid residue and A 2 is an α-imino acid residue.
Claim 9
Dependent Claim 12 words
A compound in accordance with claim 7 wherein A 2 is L-proline.
Claim 10
Dependent Claim 59 words
A compound having the formula ##STR15## or an alkyl ester or a salt thereof, wherein R 1 is hydrogen, or ##STR16## or an alkyl ester or a salt thereof, wherein R 2 is hydrogen, alkyl or phenylalkyl; and A 1 and A 2 each is independently proline, 4-hydroxyproline, 4,4-ethylenedioxyproline, 4-methoxyproline, 4-thiazolidinecarboxylic acid, tryptophane, glycine, alanine, leucine, isoleucine or valine.
Claim 11
Dependent Claim 59 words
A compound having the formula ##STR15## or an alkyl ester or a salt thereof, wherein R 1 is hydrogen, or ##STR16## or an alkyl ester or a salt thereof, wherein R 2 is hydrogen, alkyl or phenylalkyl; and A 1 and A 2 each is independently proline, 4-hydroxyproline, 4,4-ethylenedioxyproline, 4-methoxyproline, 4-thiazolidinecarboxylic acid, tryptophane, glycine, alanine, leucine, isoleucine or valine.
Claim 12
Dependent Claim 8 words
The compound in accordance with claim 9, 1-(S-3-mercapto-2-methyl-1-oxopropyl)-L-prolyl-L-proline.
Claim 13
Dependent Claim 10 words
The compound in accordance with claim 9, 1-(S-3-mercapto-2-methyl-1-oxopropyl)-L-prolyl-glycine, lithium salt.
Claim 14
Dependent Claim 8 words
The compound in accordance with claim 9, (S)-1-(3-mercapto-2-methyl-1-oxopropyl)-L-prolyl-L-alanine.
Claim 15
Dependent Claim 8 words
The compound in accordance with claim 9, (S)-(3-mercapto-2-methyl-1-oxopropyl)-L-propyl-D-alanine.
Claim 16
Dependent Claim 12 words
A compound in accordance with claim 9 wherein R 1 is hydrogen.
Claim 17
Dependent Claim 12 words
A compound in accordance with claim 9 wherein R 1 is ##STR17##
Claim 18
Dependent Claim 12 words
A compound in accordance with claim 9 wherein R 2 is hydrogen.
Claim 19
Dependent Claim 12 words
A compound in accordance with claim 9 wherein R 2 is alkyl.
Claim 20
Dependent Claim 12 words
A compound in accordance with claim 9 wherein R 2 is phenylalkyl.
Claim 21
Dependent Claim 23 words
A compound in accordance with claim 9 wherein A 1 is an α-amino acid residue and A 2 is an α-imino acid residue.
Claim 22
Dependent Claim 12 words
A compound in accordance with claim 9 wherein A 2 is L-proline.
Claim 23
Dependent Claim 67 words
A pharmaceutically acceptable compound having the formula ##STR18## or an alkyl ester or a salt thereof, wherein R 1 is hydrogen, or ##STR19## R 2 is hydrogen, alkyl or phenylalkyl; and A 1 and A 2 each is an α-amino or α-imino acid residue joined through a peptide bond; said compound when administered to a mammal with elevated blood pressure being capable of reducing the blood pressure.
Claim 24
Dependent Claim 67 words
A pharmaceutically acceptable compound having the formula ##STR18## or an alkyl ester or a salt thereof, wherein R 1 is hydrogen, or ##STR19## R 2 is hydrogen, alkyl or phenylalkyl; and A 1 and A 2 each is an α-amino or α-imino acid residue joined through a peptide bond; said compound when administered to a mammal with elevated blood pressure being capable of reducing the blood pressure.
Claim 25
Independent Claim 75 words
A method for reducing blood pressure in mammals which comprises administering to a mammal in need thereof, an effective amount of a compound having the formula ##STR20## or an alkyl ester or a physiologically acceptable salt thereof, wherein R 1 is hydrogen, or ##STR21## R 2 is hydrogen, alkyl or phenylalkyl, n is 0 or 1; and A 1 and A 2 each is an α-amino or, α-imino acid residue joined through a peptide bond.
Claim 26
Independent Claim 75 words
A method for reducing blood pressure in mammals which comprises administering to a mammal in need thereof, an effective amount of a compound having the formula ##STR20## or an alkyl ester or a physiologically acceptable salt thereof, wherein R 1 is hydrogen, or ##STR21## R 2 is hydrogen, alkyl or phenylalkyl, n is 0 or 1; and A 1 and A 2 each is an α-amino or, α-imino acid residue joined through a peptide bond.

References Cited (Backward Citations)

US3246025A Cited
US3897480A Cited
US4248883A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-08-03 1991-02-02 1991-08-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-08-03 1995-02-02 1995-08-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-08-03 1999-02-02 1999-08-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag